News
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results